O'Brien Greene & Co. Inc P Lx Pharma Inc. Call Options Transaction History
O'Brien Greene & Co. Inc
- $303 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLXP
# of Institutions
5Shares Held
61.7KCall Options Held
0Put Options Held
0About PLx Pharma Inc.
- Ticker PLXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,137,700
- Description
- PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...